Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) EBIT Margin (2020 - 2025)

Roivant Sciences (ROIV) has disclosed EBIT Margin for 6 consecutive years, with 16966.13% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin fell 1392354.0% year-over-year to 16966.13%, compared with a TTM value of 20987.61% through Dec 2025, down 4151140.0%, and an annual FY2025 reading of 3453.32%, changed N/A over the prior year.
  • EBIT Margin was 16966.13% for Q4 2025 at Roivant Sciences, up from 19492.87% in the prior quarter.
  • Across five years, EBIT Margin topped out at 13805.75% in Q4 2023 and bottomed at 19492.87% in Q3 2025.
  • Average EBIT Margin over 5 years is 4655.63%, with a median of 2355.12% recorded in 2021.
  • The sharpest move saw EBIT Margin surged 1602295bps in 2023, then plummeted -1684834bps in 2024.
  • Year by year, EBIT Margin stood at 2355.12% in 2021, then grew by 6bps to 2217.2% in 2022, then soared by 723bps to 13805.75% in 2023, then crashed by -122bps to 3042.59% in 2024, then plummeted by -458bps to 16966.13% in 2025.
  • Business Quant data shows EBIT Margin for ROIV at 16966.13% in Q4 2025, 19492.87% in Q3 2025, and 13130.05% in Q2 2025.